Endoscopic Vessel Harvesting: Market Size & Forecast 2026

Endoscopic vessel harvesting systems encompass specialized endoscopic instruments, cameras, and energy devices surgeons use to extract conduit vessels for coronary and peripheral bypass surgery through minimally invasive approaches. The technology has become the standard of care in many cardiac surgery centers due to reduced wound infections, less postoperative pain, shorter hospital stays, and faster patient recovery compared to traditional open vein harvesting. Market participants offer both reusable console-based systems and single-use disposable kits, with the latter gaining increasing adoption as hospitals prioritize patient safety, workflow efficiency, and reduced sterilization overhead.

• •Primary clinical application is Coronary Artery Bypass Grafting (CABG), which accounts for the largest share of EVH utilization globally
• •Disposable component and system configurations represent a growing product category due to infection-control and operational efficiency benefits
• •The United States and Europe together account for the majority of current market revenue, though Asia-Pacific is expanding as cardiac surgical access improves

The rising global burden of cardiovascular disease is the primary demand catalyst, with coronary artery disease remaining a leading cause of mortality worldwide and driving sustained surgical procedure volumes. Aging demographics in developed and emerging markets increase the pool of patients requiring bypass procedures, while clinical evidence demonstrates that endoscopic harvesting reduces leg-wound complications, a significant advantage given that wound infection is one of the most common causes of readmission after cardiac surgery. Healthcare cost-containment pressures have paradoxically supported EVH adoption, as shorter recovery times and fewer complications translate to lower overall episode-of-care costs that offset higher upfront device expenditures.

• •Growing surgeon preference for minimally invasive techniques that reduce postoperative morbidity, length of stay, and rehabilitation timelines
• •Expanding cardiac surgical infrastructure across emerging markets in Asia-Pacific, Latin America, and the Middle East
• •Technological advancements in endoscopic imaging, energy-based vessel sealing, and dissection tools that improve safety and shorten surgeon learning curves

Product segmentation distinguishes between reusable endoscopic systems with modular consoles and fully disposable single-use kits, with the disposable segment capturing a growing share as hospitals prioritize infection control and procedural throughput. Regional analysis shows North America maintaining its leadership position due to high CABG volumes, favorable reimbursement frameworks, and early adoption of advanced surgical technologies. Europe follows as the second-largest market, while Asia-Pacific has emerged as the fastest-growing region as China, India, Japan, and Southeast Asian nations invest in cardiac surgical capacity and adopt internationally recognized clinical standards.

• •North America leads in revenue generation, supported by high cardiovascular disease prevalence, established surgical infrastructure, and favorable reimbursement policies
• •Europe holds the second-largest regional share, with mature markets in Germany, the United Kingdom, and France driving steady adoption
• •Asia-Pacific is the fastest-expanding region, driven by rising cardiac surgery volumes and healthcare infrastructure investment across China, India, Japan, and Southeast Asia

What are the recent trends and outlook?

The market is positioned for sustained moderate growth through the early 2030s, with demand increasingly shaped by hospital procurement preferences for single-use systems that mitigate cross-contamination risk and reduce sterilization processing costs. Value-based care models are influencing purchasing decisions as healthcare systems evaluate EVH devices based on total procedural cost and patient outcome metrics rather than upfront unit price alone. Looking ahead, integration of robotic-assisted harvesting platforms, enhanced endoscopic imaging technologies, and expanded indications into peripheral vascular bypass procedures could broaden the addressable market and accelerate adoption in both developed and emerging healthcare systems.

• •Single-use disposable EVH systems are expected to gain further market share as infection-control and hospital efficiency priorities remain elevated
• •Emerging market penetration in Asia-Pacific and Latin America is projected to outpace developed market growth as cardiac surgical access continues expanding
• •Robotic-assisted and computer-guided vessel harvesting technologies represent the next innovation frontier, with potential to further reduce surgical trauma and improve procedural consistency